These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23604187)

  • 1. The German evidence-based guidelines for Hodgkin's lymphoma. Aspects for radiation oncologists.
    Eich HT; Kriz J; Schmidberger H; Böll B; Klimm B; Rancea M; Müller RP; Engert A;
    Strahlenther Onkol; 2013 Jun; 189(6):445-7. PubMed ID: 23604187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence - consequences for the GPOH-HD 2003 protocol.
    Körholz D; Kluge R; Wickmann L; Hirsch W; Lüders H; Lotz I; Dannenberg C; Hasenclever D; Dörffel W; Sabri O
    Onkologie; 2003 Oct; 26(5):489-93. PubMed ID: 14605468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
    Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
    Blood; 1999 Jul; 94(2):429-33. PubMed ID: 10397709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of positron emission tomography (PET) in treatment control and relapse of Hodgkin's disease.
    Lang O; Bihl H; Hültenschmidt B; Sautter-Bihl ML
    Strahlenther Onkol; 2001 Mar; 177(3):138-44. PubMed ID: 11285771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
    Kriz J; Reinartz G; Dietlein M; Kobe C; Kuhnert G; Haverkamp H; Haverkamp U; Engenhart-Cabillic R; Herfarth K; Lukas P; Schmidberger H; Staar S; Hegerfeld K; Baues C; Engert A; Eich HT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):46-53. PubMed ID: 25863753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of Hodgkin lymphoma: chances of remission are good, treatment tolerance needs improvement].
    Bischoff M
    MMW Fortschr Med; 2011 Oct; 153(41):17. PubMed ID: 22046834
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemoradiotherapy in early Hodgkin lymphoma.
    André MP
    Hematol Oncol Clin North Am; 2014 Feb; 28(1):33-47. PubMed ID: 24287066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).
    Eich HT; Gossmann A; Engert A; Kriz J; Bredenfeld H; Hansemann K; Skripnitchenko R; Brillant C; Pfistner B; Staar S; Diehl V; Müller RP;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1187-92. PubMed ID: 17703895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
    Specht L
    Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma].
    Kluge R; Körholz D
    Klin Padiatr; 2011 Nov; 223(6):315-9. PubMed ID: 22012607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of early and intermediate stage Hodgkin's lymphoma in the German Hodgkin's Lymphoma Study Group.
    Wiedenmann S; Schiller P; Paulus U; Wolf J
    Ann Oncol; 2002; 13 Suppl 1():84-5. PubMed ID: 12078909
    [No Abstract]   [Full Text] [Related]  

  • 12. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PET in Hodgkin's lymphoma and its impact on radiation oncology.
    Kobe C; Dietlein M; Kriz J; Furth C; Fuchs M; Borchmann P; Engert A; Eich HT
    Expert Rev Anticancer Ther; 2010 Sep; 10(9):1419-28. PubMed ID: 20836677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma.
    Crump M; Herst J; Baldassarre F; Sussman J; MacEachern J; Hodgson D; Cheung MC
    Blood; 2015 Mar; 125(11):1708-16. PubMed ID: 25605371
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
    Körholz D; Mauz-Körholz C; Vordermark D; Kluge R; Dieckmann K
    Klin Padiatr; 2014 Nov; 226(6-7):307-8. PubMed ID: 25431863
    [No Abstract]   [Full Text] [Related]  

  • 16. Early-stage Hodgkin's lymphoma.
    Armitage JO
    N Engl J Med; 2010 Aug; 363(7):653-62. PubMed ID: 20818856
    [No Abstract]   [Full Text] [Related]  

  • 17. Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG).
    Eich HT; Müller RP; Engenhart-Cabillic R; Lukas P; Schmidberger H; Staar S; Willich N;
    Strahlenther Onkol; 2008 Aug; 184(8):406-10. PubMed ID: 18956517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Staging of Hodgkin's disease and choice of treatment].
    Sakano T
    Nihon Rinsho; 1983 Nov; 41(11):2482-9. PubMed ID: 6672284
    [No Abstract]   [Full Text] [Related]  

  • 19. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
    Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
    Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of radiation therapy in the management of aggressive non-Hodgkin's lymphomas.
    Rübe Ch; Nguyen TP; Brinkmann R
    Onkologie; 2002 Jun; 25(3):214-20. PubMed ID: 12119455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.